MedPath

Assessment of kanashatahwadi kashaya orally alongwith Asnadi Niruha basti in the management of Polycystic ovarian Disease

Not Applicable
Conditions
Health Condition 1: E889- Metabolic disorder, unspecifiedHealth Condition 2: E889- Metabolic disorder, unspecified
Registration Number
CTRI/2023/08/055939
Lead Sponsor
Department of Prasuti Tantra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Diagnosed with PCOS as defined by Rotterdam criteria.

2)Irregular menses/Scanty menses due to PCOD.

3)Elevated LH and altered ratio of LH:FSH ratio >3

4)Clinical or Biomedical evidence of Hyperandrogenism.

5)Both married and unmarried patients.

Exclusion Criteria

1)Diagnosed cases of congenital malformation.

2)Benign and malignant lesion of reproductive organ.

3)Endocrinal dysfunction like Thyroid dysfunction and Adrenal hyperplasia.

4)Patient with Anorectal disease.

5)Patients with HIV/VDRL/HbsAg positive.

6)Patients with Pelvic inflammatory disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the therapeutic efficacy of Oral administration of Kanashatahwadi Kashaya & Asanadi Niruha Basti in 90 days of study period in the management of Polycystic Ovarian Disease <br/ ><br>To explore and understand Ayurvedic theories treatment and practices on Polycystic Ovarian DiseaseTimepoint: 90 days
Secondary Outcome Measures
NameTimeMethod
In today scenario disorder of menstruation is the commonest amongst all the gyneacological complaints, which have a direct effect on the physical health as well as psychological health & reproductive health of female.Timepoint: 90 days
© Copyright 2025. All Rights Reserved by MedPath